Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now full pipeline small index

Albuminuria: full-pipeline trial registry

2 of 5 indexed Albuminuria trials are currently recruiting.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

Albuminuria: 5 US clinical trials tracked, 2 recruiting.

Albuminuria is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Geisinger Clinic, running 2 of these trials.

Enrollment posture brief

Registry condition albuminuria

OPEN 2 | RECR 40% | LATE 1 | EARLY 1 | RANK #3391 | SPON 2

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Albuminuria (this)40%
Open-enrollment share among volume-matched conditions near Albuminuria

Albuminuria lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Albuminuria on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Albuminuria is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Albuminuria research.

    Geisinger Clinic accounts for 2 of 5 trials (40%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Most Albuminuria trials plan to enrol fewer than 100 people.

    Median target enrolment is 50 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.

  4. Albuminuria research is mostly interventional.

    4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Albuminuria records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Mailed Urinalysis Smartphone Kit Other
1 trials
Remote counseling Behavioral
1 trials
Amiloride Drug
1 trials
Spironolactone Drug
1 trials
Montelukast Drug
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Albuminuria trials. A trial with sites in several states counts in each.

Pennsylvania 2 trials
Colorado 1 trials
Arizona 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Albuminuria page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Albuminuria condition card totals 5 registered trials; most-linked intervention Mailed Urinalysis Smartphone Kit; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.